NanoEcho AB (publ) (STO:NANECH)
Sweden · Delayed Price · Currency is SEK 0.0498
-0.0006 (-1.19%)
At close: Apr 24, 2026
NanoEcho AB Earnings Call Transcripts
Fiscal Year 2024
-
Transitioned to clinical phase after completing product development and regulatory milestones. Net loss increased to SEK 8.7 million with no revenue, but a successful rights issue secured 12 months of capital for clinical trials. Market approval is targeted for H2 2027.